Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
暂无分享,去创建一个
A. Draguhn | C. Bruehl | R. Fink | H. Katus | H. Ehmke | Dierk Thomas | A. Schwoerer | P. Schweizer | M. Koenen | C. Seyler | Pascal Geschwill | M. Mosqueira | T. Fink | Pessah Yampolsky | Sebastian Nauck | Monika Witzenberger | M. Kruska | P. Yampolsky
[1] Takehito Tokuyama,et al. HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycardia-Induced Cardiomyopathy in Patients With Atrial Fibrillation , 2018, Circulation. Genomic and precision medicine.
[2] M. Levin,et al. HCN2 Rescues brain defects by enforcing endogenous voltage pre-patterns , 2018, Nature Communications.
[3] P. Kantor,et al. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure. , 2017, Journal of the American College of Cardiology.
[4] M. Levin,et al. Coordinating heart morphogenesis: A novel role for hyperpolarization-activated cyclic nucleotide-gated (HCN) channels during cardiogenesis in Xenopus laevis , 2017, Communicative & integrative biology.
[5] W. Rottbauer,et al. Erratum: Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression , 2016, Nature Communications.
[6] K. Nakao,et al. Ectopic automaticity induced in ventricular myocytes by transgenic overexpression of HCN2. , 2015, Journal of molecular and cellular cardiology.
[7] J. Papp,et al. Selective Na+/Ca2+ exchanger inhibition prevents Ca2+ overload‐induced triggered arrhythmias , 2014, British journal of pharmacology.
[8] J. Tardif,et al. Ivabradine in stable coronary artery disease without clinical heart failure. , 2014, The New England journal of medicine.
[9] A. Draguhn,et al. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. , 2014, Journal of the American College of Cardiology.
[10] R. Redon,et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[11] B. Lewartowski,et al. Ivabradine Protects Against Ventricular Arrhythmias in Acute Myocardial Infarction in the Rat , 2014, Journal of cellular physiology.
[12] J. Papp,et al. ORM‐10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart , 2013, British journal of pharmacology.
[13] A. Draguhn,et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. , 2013, European heart journal.
[14] K. Chien,et al. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells , 2013, Nature Cell Biology.
[15] G. Wang,et al. HCN4 Dynamically Marks the First Heart Field and Conduction System Precursors , 2013, Circulation research.
[16] E. Letavernier,et al. The role of calpains in myocardial remodelling and heart failure. , 2012, Cardiovascular research.
[17] J. McArdle,et al. A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation , 2012, Neurobiology of Disease.
[18] A. Draguhn,et al. cAMP Sensitivity of HCN Pacemaker Channels Determines Basal Heart Rate But Is Not Critical for Autonomic Rate Control , 2010, Circulation. Arrhythmia and electrophysiology.
[19] Michael Böhm,et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2010, The Lancet.
[20] Alan Garfinkel,et al. So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. , 2010, Biophysical journal.
[21] P. Bruneval,et al. Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression. , 2010, European heart journal.
[22] H. Ehmke,et al. Control of heart rate by cAMP sensitivity of HCN channels , 2009, Proceedings of the National Academy of Sciences.
[23] H. Katus,et al. Transcription profiling of HCN-channel isotypes throughout mouse cardiac development , 2009, Basic Research in Cardiology.
[24] H. Strauss,et al. Expression and distribution of voltage-gated ion channels in ferret sinoatrial node. , 2009, Physiological genomics.
[25] G. Heusch,et al. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. , 2008, European heart journal.
[26] S. Nattel,et al. Molecular basis of funny current (If) in normal and failing human heart. , 2008, Journal of molecular and cellular cardiology.
[27] T. Hewett,et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.
[28] H. Katus,et al. Cardiac-specific activation of Cre expression at late fetal development. , 2007, Biochemical and biophysical research communications.
[29] J. Zavadil,et al. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. , 2007, Physiological genomics.
[30] D. Allen,et al. Intracellular calcium handling in ventricular myocytes from mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[31] Tobias Opthof,et al. Embryological development of pacemaker hierarchy and membrane currents related to the function of the adult sinus node: implications for autonomic modulation of biopacemakers , 2007, Medical & Biological Engineering & Computing.
[32] D. Roden,et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. , 2006, The Journal of clinical investigation.
[33] K. Mani,et al. Death begets failure in the heart. , 2005, The Journal of clinical investigation.
[34] Jeffrey L. Anderson,et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.
[35] K. P. Roos,et al. Functional Adult Myocardium in the Absence of Na+-Ca2+ Exchange: Cardiac-Specific Knockout of NCX1 , 2004, Circulation research.
[36] T. Thum,et al. Hallmarks of ion channel gene expression in end‐stage heart failure , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] Antonis A Armoundas,et al. Role of Sodium-Calcium Exchanger in Modulating the Action Potential of Ventricular Myocytes From Normal and Failing Hearts , 2003, Circulation research.
[38] G. Breithardt,et al. Pacemaker channel dysfunction in a patient with sinus node disease. , 2003, The Journal of clinical investigation.
[39] J. Ross,et al. Calcium and heart failure: the cycle game , 2003, Nature Medicine.
[40] S. Houser,et al. [Na+]i handling in the failing human heart. , 2003, Cardiovascular research.
[41] U. Ravens,et al. The hyperpolarization-activated current If in ventricular myocytes of non-transgenic and β2-adrenoceptor overexpressing mice , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.
[42] T. Opthof,et al. If Current and Spontaneous Activity in Mouse Embryonic Ventricular Myocytes , 2001, Circulation research.
[43] G. Váradi,et al. A Ca2+-Dependent Transgenic Model of Cardiac Hypertrophy: A Role for Protein Kinase C&agr; , 2001 .
[44] Akinori Noma,et al. Molecular Characterization of the Hyperpolarization-activated Cation Channel in Rabbit Heart Sinoatrial Node* , 1999, The Journal of Biological Chemistry.
[45] G. Mitchell,et al. Measurement of heart rate and Q-T interval in the conscious mouse. , 1998, American journal of physiology. Heart and circulatory physiology.
[46] C A Beltrami,et al. Apoptosis in the failing human heart. , 1997, The New England journal of medicine.
[47] G Sani,et al. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. , 1997, Circulation.
[48] A. Picard,et al. Structure and regulation of the mouse cardiac troponin I gene. , 1994, The Journal of biological chemistry.
[49] S. Schiaffino,et al. Regional differences in troponin I isoform switching during rat heart development. , 1993, Developmental biology.
[50] Dario DiFrancesco,et al. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP , 1991, Nature.
[51] M. Boyett,et al. Factors affecting intracellular sodium during repetitive activity in isolated sheep Purkinje fibres. , 1987, The Journal of physiology.
[52] H. Glitsch,et al. The contribution of Na and K ions to the pacemaker current in sheep cardiac Purkinje fibres , 1986, Pflügers Archiv.
[53] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[54] D DiFrancesco,et al. A study of the ionic nature of the pace‐maker current in calf Purkinje fibres. , 1981, The Journal of physiology.
[55] David M. Harris,et al. Persistent increases in Ca2+ influx through Cav1.2 shortens action potential and causes Ca2+ overload-induced afterdepolarizations and arrhythmias , 2015, Basic Research in Cardiology.
[56] Dario DiFrancesco,et al. Cycling in the Mechanism of Pacemaking Cardiac Pacemaking : Historical Overview and Future Directions , 2010 .
[57] Mohit M. Jain,et al. Isolation, culture, and functional analysis of adult mouse cardiomyocytes. , 2007, Methods in molecular medicine.
[58] K. Kugiyama,et al. Role of Protein Kinase C , 2005 .